These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18205948)

  • 21. Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1-ETO activity.
    Park S; Chen W; Cierpicki T; Tonelli M; Cai X; Speck NA; Bushweller JH
    Blood; 2009 Apr; 113(15):3558-67. PubMed ID: 19204326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
    Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD
    Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dimer-tetramer transition controls RUNX1/ETO leukemogenic activity.
    Wichmann C; Becker Y; Chen-Wichmann L; Vogel V; Vojtkova A; Herglotz J; Moore S; Koch J; Lausen J; Mäntele W; Gohlke H; Grez M
    Blood; 2010 Jul; 116(4):603-13. PubMed ID: 20430957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein.
    Melnick AM; Westendorf JJ; Polinger A; Carlile GW; Arai S; Ball HJ; Lutterbach B; Hiebert SW; Licht JD
    Mol Cell Biol; 2000 Mar; 20(6):2075-86. PubMed ID: 10688654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors.
    Lutterbach B; Westendorf JJ; Linggi B; Patten A; Moniwa M; Davie JR; Huynh KD; Bardwell VJ; Lavinsky RM; Rosenfeld MG; Glass C; Seto E; Hiebert SW
    Mol Cell Biol; 1998 Dec; 18(12):7176-84. PubMed ID: 9819404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multivalent binding of the ETO corepressor to E proteins facilitates dual repression controls targeting chromatin and the basal transcription machinery.
    Guo C; Hu Q; Yan C; Zhang J
    Mol Cell Biol; 2009 May; 29(10):2644-57. PubMed ID: 19289505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis.
    Yan M; Ahn EY; Hiebert SW; Zhang DE
    Blood; 2009 Jan; 113(4):883-6. PubMed ID: 19036704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel RNA-binding properties of the MTG chromatin regulatory proteins.
    Rossetti S; van Unen L; Sacchi N; Hoogeveen AT
    BMC Mol Biol; 2008 Oct; 9():93. PubMed ID: 18950503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription.
    Wood JD; Nucifora FC; Duan K; Zhang C; Wang J; Kim Y; Schilling G; Sacchi N; Liu JM; Ross CA
    J Cell Biol; 2000 Sep; 150(5):939-48. PubMed ID: 10973986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A TAF4-homology domain from the corepressor ETO is a docking platform for positive and negative regulators of transcription.
    Wei Y; Liu S; Lausen J; Woodrell C; Cho S; Biris N; Kobayashi N; Wei Y; Yokoyama S; Werner MH
    Nat Struct Mol Biol; 2007 Jul; 14(7):653-61. PubMed ID: 17572682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The AML1/ETO fusion protein activates transcription of BCL-2.
    Klampfer L; Zhang J; Zelenetz AO; Uchida H; Nimer SD
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14059-64. PubMed ID: 8943060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors.
    Cai Y; Xu Z; Xie J; Ham AJ; Koury MJ; Hiebert SW; Brandt SJ
    Biochem Biophys Res Commun; 2009 Dec; 390(2):295-301. PubMed ID: 19799863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear import and subnuclear localization of the proto-oncoprotein ETO (MTG8).
    Odaka Y; Mally A; Elliott LT; Meyers S
    Oncogene; 2000 Jul; 19(32):3584-97. PubMed ID: 10951564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family.
    Gamou T; Kitamura E; Hosoda F; Shimizu K; Shinohara K; Hayashi Y; Nagase T; Yokoyama Y; Ohki M
    Blood; 1998 Jun; 91(11):4028-37. PubMed ID: 9596646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The AML1/ETO(MTG8) and AML1/Evi-1 leukemia-associated chimeric oncoproteins accumulate PEBP2beta(CBFbeta) in the nucleus more efficiently than wild-type AML1.
    Tanaka K; Tanaka T; Kurokawa M; Imai Y; Ogawa S; Mitani K; Yazaki Y; Hirai H
    Blood; 1998 Mar; 91(5):1688-99. PubMed ID: 9473235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ETO interacting proteins.
    Hug BA; Lazar MA
    Oncogene; 2004 May; 23(24):4270-4. PubMed ID: 15156183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular targeting of aberrant transcription factors in leukemia: strategies for RUNX1/ETO.
    Wichmann C; Grez M; Lausen J
    Curr Drug Targets; 2010 Sep; 11(9):1181-91. PubMed ID: 20583973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.
    Erickson PF; Dessev G; Lasher RS; Philips G; Robinson M; Drabkin HA
    Blood; 1996 Sep; 88(5):1813-23. PubMed ID: 8781439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein.
    Chevallier N; Corcoran CM; Lennon C; Hyjek E; Chadburn A; Bardwell VJ; Licht JD; Melnick A
    Blood; 2004 Feb; 103(4):1454-63. PubMed ID: 14551142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressor protein p53 recruits human Sin3B/HDAC1 complex for down-regulation of its target promoters in response to genotoxic stress.
    Bansal N; Kadamb R; Mittal S; Vig L; Sharma R; Dwarakanath BS; Saluja D
    PLoS One; 2011; 6(10):e26156. PubMed ID: 22028823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.